Search
InsiderInsights.com

St Peter Steven (1352447)

St Peter Steven has been a registered insider at 3 firms since 2006. As Chief Executive Officer at Aratana Therapeutics, St Peter Steven last made a transaction on 12/17/2018. As a Director at PharmAthene, Inc, St Peter Steven last made a transaction on 1/4/2017. As a Director at Omrix Biopharmaceuticals, Inc., St Peter Steven last made a transaction on 8/13/2007.

ARATANA THERAPEUTICS, INC. (PETX)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
3 100% 63% 59% 118 1 Year 3 0% -- -- --
3 100% 58% 27% 118 9 Month 3 0% -- -- --
3 67% 69% 84% 154 6 Month 3 0% -- -- --
3 67% 41% 22% 149 3 Month 3 0% -- -- --
3 33% 2% -2% 30 1 Month 3 0% -- -- --
3 100% 8% 7% 17 1 Week 3 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
13 85% -19% -9% 143 1 Year 13 0% -- -- --
15 73% -13% -18% 99 9 Month 15 0% -- -- --
17 76% -6% -16% 122 6 Month 17 0% -- -- --
17 71% -6% -14% 94 3 Month 17 0% -- -- --
17 59% -2% -2% 52 1 Month 17 0% -- -- --
17 47% -0% 1% 40 1 Week 17 0% -- -- --
Scorecards Updated 6/14/2023 07:24 PM EST Latest Transaction Date: 12/17/2018
Average days between Transaction and Entered Dates: 2

PHARMATHENE, INC (PIP, ALT)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% 20% -- -- 1 Year 1 100% 5% -- --
1 0% -5% -- -- 9 Month 1 0% -2% -- --
2 0% -41% -41% 61 6 Month 2 50% 8% 8% 38
3 67% -20% 2% 93 3 Month 3 100% 138% 17% 388
3 67% 0% 0% 1 1 Month 3 67% 246% 331% 408
3 67% 1% 1% 3 1 Week 3 100% 254% 345% 413
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 10/16/2021 09:23 AM EST Latest Transaction Date: 1/4/2017
Average days between Transaction and Entered Dates: 3

Omrix Biopharmaceuticals, Inc. (OMRI)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% -22% -- -- 1 Year 1 0% -- -- --
1 100% -48% -- -- 9 Month 1 0% -- -- --
1 100% -12% -- -- 6 Month 1 0% -- -- --
1 0% 33% -- -- 3 Month 1 0% -- -- --
1 0% 26% -- -- 1 Month 1 0% -- -- --
1 100% -2% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/14/2023 07:24 PM EST Latest Transaction Date: 8/13/2007
Average days between Transaction and Entered Dates: 1
© 2024 InsiderInsights.com